Switch to:
More From Other Websites
Eight Undervalued Key Antibiotics Players Feb 25 2015
Prem Watsa's Stock Buys and Sells of Q4 Feb 17 2015
Dana Holding Set to Join the S&P MidCap 400 Jan 20 2015
Cubist Announces Withdrawal of Listing of CVRs (CBSTZ) from NASDAQ Global Select Market Jan 13 2015
Cubist Announces Withdrawal of Listing of CVRs (CBSTZ) from NASDAQ Global Select Market Jan 13 2015
Teixobactin And iChip Promise Hope Against Antibiotic Resistance Jan 08 2015
Cramer's Mad Dash: Pharma movers Dec 24 2014
Merck Finally Gets Some Good News on Cubist Dec 22 2014
Approval of new antibiotic by Cubist to help in $100 trillion global fight Dec 22 2014
[$$] FDA Approves Cubist's Experimental Antibiotic Zerbaxa Dec 19 2014
FDA Approves Second Cubist Antibiotic Of 2014 Dec 19 2014
Cubist Announces FDA Approval of New Antibiotic ZERBAXA™ (Ceftolozane/Tazobactam) for Complicated... Dec 19 2014
Cubist Announces FDA Approval of New Antibiotic ZERBAXA™ (Ceftolozane/Tazobactam) for Complicated... Dec 19 2014
FDA approves Cubists' drug for antibiotic-resistant bacteria Dec 19 2014
Merck Begins Tender Offer to Acquire Cubist Dec 19 2014
$100 trillion Superbugs threat Dec 18 2014
Tetraphase Jumps As 'Superbug' Drug Scores In Trial Dec 18 2014
Cubist Pharma downgraded by UBS Dec 17 2014
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Cubist... Dec 15 2014
Charting the Market Dec 13 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK